Chemoinformaics analysis of Naringenin 7-O-Beta- Glucoside
| Molecular Weight | 476.434 | nRot | 5 |
| Heavy Atom Molecular Weight | 452.242 | nRig | 25 |
| Exact Molecular Weight | 476.132 | nRing | 4 |
| Solubility: LogS | -4.226 | nHRing | 2 |
| Solubility: LogP | 1.057 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 63.235 |
| nHD | 5 | BPOL | 32.757 |
| QED | 0.382 |
| Synth | 4.074 |
| Natural Product Likeliness | 2.11 |
| NR-PPAR-gamma | 0.93 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.413 |
| HIA | 0.834 |
| CACO-2 | -6.354 |
| MDCK | 0.000036 |
| BBB | 0.383 |
| PPB | 0.80626 |
| VDSS | 0.477 |
| FU | 0.227863 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.082 |
| CYP2c9-inh | 0.028 |
| CYP2c9-sub | 0.809 |
| CYP2d6-inh | 0.252 |
| CYP2d6-sub | 0.256 |
| CYP3a4-inh | 0.103 |
| CYP3a4-sub | 0.172 |
| CL | 4.266 |
| T12 | 0.373 |
| hERG | 0.028 |
| Ames | 0.507 |
| ROA | 0.218 |
| SkinSen | 0.068 |
| Carcinogencity | 0.855 |
| EI | 0.023 |
| Respiratory | 0.044 |
| NR-Aromatase | 0.046 |
| Antiviral | Yes |
| Prediction | 0.800909 |